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Abstract
Elevated blood pressure, a major risk factor for ischemic heart disease, heart failure, and stroke, is 
the leading global risk for mortality. Despite global efforts to combat hypertension, it continues to 
exert a significant health and economic burden on low- and middle-income country (LMIC) 
populations, thereby triggering the need to address the problem by way of novel approaches. The 
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Global Alliance for Chronic Diseases has funded 15 research projects related to hypertension 
control in low-resource settings worldwide. These research projects have developed and evaluated 
several important innovative approaches to hypertension control, including: community 
engagement, salt reduction, salt substitution, task redistribution, mHealth, and fixed-dose 
combination therapies. In this paper, we briefly review the rationale for each of these innovative 
approaches, as well as summarize the experience of some of the research teams in these respective 
areas. Where relevant, we also draw upon the wider literature to illustrate how these approaches to 
hypertension control are being implemented in LMICs. The studies outlined in this report 
demonstrate innovative and practical methods of implementing for improving hypertension control 
in diverse environments and contexts worldwide.
Keywords
Hypertension; Low- and middle-income countries; Community engagement; mHealth; Task 
redistribution; Salt reduction; Salt substitution; Polypill
Introduction
Cardiovascular disease (CVD) is the leading cause of mortality in the world, resulting in 
17.3 million deaths annually, with 80% of these deaths occurring in low- and middle-income 
countries (LMICs).1 Elevated blood pressure, a major risk factor for ischemic heart disease, 
heart failure, and stroke,2 is the leading global risk for mortality.1 Despite global efforts to 
combat hypertension, treatment and control rates are very low in LMICs.3 Given the 
continued significant health and economic burden on LMIC populations, there is an urgent 
need to address the problem by way of novel approaches.
Founded in 2009, the Global Alliance for Chronic Diseases (GACD), funds, coordinates, 
and facilitates global collaborations in implementation research, focusing on the prevention 
and treatment of chronic non-communicable diseases in LMICs and vulnerable populations 
in high-income countries.4 The first round of GACD-sponsored research projects focused on 
hypertension, and included 15 research teams from around the world.5 These research 
projects have involved the development and evaluation of several important innovative 
approaches to hypertension control, including: community engagement, salt reduction, salt 
substitution, task redistribution, mHealth, and fixed-dose combination therapies.
In this paper, we briefly review the rationale for each of these innovative approaches, as well 
as summarize the experience of some of the GACD teams in these respective areas. Where 
relevant, we also draw upon the wider literature to illustrate how these approaches to 
hypertension control are being implemented in LMICs.
Community Engagement
Health care delivery and health systems often fail to meet the needs and expectations of 
those who need them.6, 7 Community engagement seeks to address this problem by 
optimizing the appropriateness and alignment of health care to the cultural, social, 
economic, and environmental setting.8, 9 It encompasses participation, mobilization, and 
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empowerment (Figure 1).10 Participation refers to the active or passive engagement of the 
community in health services.10, 11 Mobilization furthers this engagement through 
facilitation by health professionals, while empowerment involves a capacity-building process 
to engage communities in planning, implementing and/or evaluating activities to achieve 
more sustainable health improvements.10, 11 Community engagement has shown promise in 
supporting interventions to improve health outcomes related to both HIV/AIDS as well as 
maternal and child health.12, 13 However, traditional methods for determining efficacy of 
community engagement are inadequate because there are significant challenges in teasing 
out the independent effects of the intervention vis a vis the process of community 
engagement itself.
Four GACD projects described herein have been conducted in Tanzania, Kenya, Colombia, 
Malaysia, India, and Canada. The investigators of these GACD projects have adopted a 
diverse range of community engagement activities, targeted at both individuals and systems, 
in order to identify barriers and facilitators for the care of hypertension, and thereby tailor 
the intervention to the local context (Table 1). Prior to initiating each of these studies, 
investigators and research staff met with community leaders, health personnel, and other 
relevant community stakeholders, to facilitate entry to the communities and to appropriately 
contextualize their approaches. Components of community engagement included (1) 
individual interviews with diverse stakeholders; (2) focus group discussions (FGDs) with 
hypertension patients; (3) workshops with local community health workers (CHWs) and 
clinicians to refine the intervention and training materials, thus enhancing the capacity of 
CHWs to deliver the intervention by employing relevant and easy-to-use tools; (4) 
community social events and gatherings; and (5) mabaraza (singular baraza), traditional East 
African community gatherings, conducted among individuals with elevated blood pressure 
and CHWs to complement the purposive sampling inherent in FGDs.14 The baraza is a 
unique and novel qualitative research setting which has been used as a form of participatory 
action research, and allows organization of a diverse and heterogeneous large group of 
individuals.15 In Tanzania and Canada, the team used an adapted tool called I-RREACH: 
Intervention and Research Readiness Engagement and Assessment of Community Health 
Care.16 This tool was developed using a community-based consensus method, and is rooted 
in participatory principles, equalizing the importance of the knowledge and perspectives of 
researchers and community stakeholders while encouraging respectful dialogue. The I-
RREACH tool is an engagement and assessment tool for improving the implementation 
readiness of researchers, organizations and communities in complex interventions, and 
consists of three phases: fact finding, stakeholder dialogue, and community member/patient 
dialogue. Another study being conducted in Canada, Malaysia, and Colombia leveraged 
non-medical community events for the purposes of screening, recruitment, intervention 
implementation, and follow-up. Using process evaluation, the GACD projects hope to add to 
our understanding of how community engagement can be used to support and strengthen 
programs aimed at improving hypertension control. Such an approach can be applied to 
more chronic diseases in low-resource settings worldwide.
The need for this research is illustrated by work elsewhere. Although it may seem self-
evident that a more participatory approach will improve the acceptability, and thus 
effectiveness of interventions, this is not fully supported by the evidence. Two projects 
Vedanthan et al. Page 4
Cardiol Clin. Author manuscript; available in PMC 2018 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
conducted in Cape Town, South Africa, and El Paso, Texas, used community-based 
participatory research approaches to design an intervention to manage hypertension and 
diabetes.17, 18 Positive results included: 1) improved self-efficacy to manage hypertension, 
2) greater improvements in health behaviours in the intervention group than in the control 
group,18 3) the development of culturally appropriate health education materials specifically 
developed for low-literacy populations,18 and 4) inclusion of learnings into local health 
sector planning for prevention and control of hypertension and diabetes.17 Although the 
authors stated that the materials were well received by participants in one study,18 no 
evidence for clinical success of community engagement was provided in either study.17, 18
Salt Reduction
Evidence shows that a reduction in the consumption of sodium—found in table salt and 
naturally occurring foods such as milk, eggs, meat, and shellfish—decreases blood pressure 
in adults and diminishes the risk of CVD.19, 20 While there is controversy about the most 
appropriate target for sodium intake, higher sodium intake in general is associated with 
poorer outcomes.21 The World Health Organization (WHO) recommends a reduction in 
sodium intake to < 2 g/day in adults.22 In 2013, member states of the United Nations 
established a target to reduce the average population salt intake by 30% by 2025,23 and 75 
countries now have strategies in place to achieve this target.24 The majority of these national 
programs are multifaceted and include initiatives such as industry engagement to lower salt 
content in foods, consumer education and awareness, establishing front-of-pack labelling 
schemes and nutrition standards for foods procured in public settings.
Three of the GACD Hypertension programs have implemented innovative salt reduction 
programs to reduce blood pressure. The first step in any program is to measure existing 
consumption patterns. These projects measured salt intake using 24-hour urine excretion and 
tried to understand people’s knowledge and eating behaviors through community surveys. 
Average daily salt excretion at baseline varied from 7 gm (Samoa);25 11 gm (Fiji); 9.5 gm 
and 8.6 gm (Andhra Pradesh and Delhi/Haryana, respectively, India); to 12.6 gm (Shanxi, 
China). The information on diet was then used to inform the different intervention strategies. 
Based on the WHO’s framework for Creating an Enabling Environment for Salt reduction,26 
the project in Fiji and Samoa used multi-faceted intervention programs to reduce salt in the 
food supply, while concurrently implementing media and community mobilization 
campaigns to increase awareness (Figure 2).27 A parallel project in Andhra Pradesh and 
Delhi/Haryana, India, used community surveys and stakeholder mapping and established a 
comprehensive food composition database (based on the George Institute’s leading 
FoodSwitch innovation for monitoring the food supply and identifying healthy choices).28 
This information is being used to inform the development of a government-led salt reduction 
strategy for India. The Little Emperor project in China trained children to encourage their 
parents to reduce salt intake. Implemented in the northern province of Shanxi, the 
researchers taught the children about the harmful effects of a salty diet and asked them to 
share the messages with adults back home. Innovative children’s approaches including 
hiding the salt pot, making up rhymes or using their status as “Little Emperors” to refuse to 
eat unhealthy foods, led to a 26% reduction in participants’ salt intake in less than 4 
months.29 More than 270 million people currently have hypertension in China; therefore, if 
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applied nationally, such a strategy could have substantial health and potential economic 
benefits.
Post-intervention monitoring in Fiji and Samoa is being finalized and has been 
supplemented through an in-depth process evaluation to better understand how the 
interventions have been implemented and potential barriers to effectiveness. Some of the 
challenges have included the changing political environment, difficulties of multi-sectoral 
action and limited experience in engaging the food industry. Mainstreaming the agendas 
with the Health Ministries in the different countries has been key to overcoming some of 
these problems. The lessons are being documented and will be disseminated widely through 
the WHO Collaborating Centre for Population Salt Reduction at the George Institute for 
Global Health, thus supporting rapid and effective translation of research into policy and 
practice. These and other studies will help to elucidate and clarify the relationship between 
sodium reduction and CVD.
Salt substitution
In addition to salt reduction, salt substitution is an innovative, non-pharmacological 
approach to reduce blood pressure. It involves the partial replacement of sodium chloride 
with any combination of other salt containing potassium, magnesium, or aluminum. A meta-
analysis from six randomized controlled trials using different combinations of salt substitute 
in comparison to usual salt found, in pooled results, that a salt substitute reduced systolic 
blood pressure by −4.9 mm Hg (95% CI: −7.3, −2.5) and diastolic blood pressure −1.5 mm 
Hg (95% CI: −2.7, −0.3). However, in the subgroup analysis, the effect was significant only 
among individuals with hypertension.30
One of the GACD projects, conducted in Peru,31 is using a population-wide approach to test 
the effect on blood pressure of replacing regular salt by an iodine-fortified substitute 
containing 25% potassium chloride and 75% sodium chloride. This involves a pragmatic 
stepped wedge trial design, in which the intervention is progressively implemented at 
random in six villages. The study has been implemented in two phases (Figure 3). The first 
phase was exploratory and included: (a) formative in-depth interviews and FGDs; (b) a 
triangle taste test, which found that a salt with 25% of potassium chloride was 
indistinguishable from regular salt;32 and (c) the development of the social marketing 
campaign targeting primarily women responsible for cooking at their home, and focused on 
promoting consumption and adherence of participants to the potassium-enriched salt. The 
second phase involved implementation of the intervention. The salt substitute has 
progressively replaced the common salt used in households, relying heavily on the social 
marketing/branding campaign as well as educational entertainment delivered by trained 
community health workers. Salt replacement has been implemented at households, bakeries, 
community kitchens and restaurants in each village.
Previous salt substitute strategies have focused on delivering the salt substitute product 
among participants with a diagnosis of hypertension, focusing almost exclusively on the 
hypertension status of the participant rather than on the product’s concept. For instance, the 
salt substitute used in other studies were no different between intervention and control arms 
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(i.e. bags were identical in appearance; products were manufactured, packaged, and labeled 
by the same company).33–35 The novelty of the Peru study relies on the implementation 
mechanisms that were developed and put in place, at the community level, aiming to 
increase the uptake of the salt substitute product as well as ensuring its sustained used over 
time in populations irrespective of hypertension status. To date, acceptability of the salt 
substitute to participants has been successful with very low rates of adverse effects related to 
its use. The study is ongoing and the fourth wedge has been concluded, with expected 
outcomes in early 2017. If successful, this project’s implementation approach may serve as a 
model for other LMIC settings.
Task Redistribution
In most countries, primary care physicians are the main providers of healthcare for 
individuals with CVD. Unfortunately, most LMICs have an inadequate number of 
physicians, especially in rural and remote regions where a majority of the population 
reside.36, 37 According to the WHO Global Health Observatory, there are 0.3 physicians 
available for every 1000 population in low income countries, 1.2 physicians per 1000 
population in lower-middle income countries, and 2.0 per 1000 population in upper-middle 
income countries.38 In response to this physician workforce shortage, appropriate strategies 
for task redistribution—from doctors to a team consisting of doctors and trained non-
physician health workers (NPHWs)—have been developed and implemented, especially in 
the areas of maternal and child health needs,39, 40 and HIV/AIDS.41
Task redistribution describes a situation where a task normally performed by a physician is 
shared between physicians and other health workers with a different or lower level of 
education and training (Figure 4).42 Task redistribution may be aided by technology, clear 
guidelines, or close supervision by physicians, to help standardize the performance and 
interpretation of certain tasks, therefore allowing them to be performed by NPHWs.43 
Systematic reviews on task-redistribution for CVD management,44, 45 indicate that not many 
studies have been conducted to test the effectiveness of task redistribution, and that further 
operational research, including detailed process evaluation, is required to understand the 
complexity, effectiveness, and cost-effectiveness of task-redistribution within different 
country contexts. Recent studies involving task-redistribution have shown that NPHWs can 
be effectively trained in the implementation of CVD prevention and management 
guidelines,46, 47 successfully screen individuals at high-risk of CVD,48, 49 provide lifestyle 
education and adherence to patients,50 and support patients with acute coronary syndrome.51 
This approach has also been shown to be cost-effective for chronic disease care in the LMIC 
context.52, 53 While there are now some published studies concerning the effectiveness of 
task-redistribution, there remain large evidence gaps and obstacles regarding the translation 
of positive research findings into routine health care delivery in LMICs, while also ensuring 
quality of care, safety, and patient acceptability. These shortcomings notwithstanding, task 
redistribution for the prevention and control of hypertension and other chronic diseases 
presents a great opportunity that could increase access to care, reduce health care costs, free 
up physician time for other tasks, and increase system efficiency in the long-term.
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Eight of the GACD projects included a component of task redistribution for the detection 
and management of hypertension. These include the redistribution of tasks related to 
hypertension screening, referral to clinicians, providing lifestyle advice, and support for 
adherence to medications to NPHWs. All the studies supported NPHWs by training them for 
two to six days, followed by re-training where required.14, 54, 55 Some studies facilitated task 
redistribution by using mHealth technology,14, 56 whereby NPHWs used electronic decision 
support tools to screen individuals in the community and link them to hypertension care. 
Process and interim evaluations have identified that the main barriers to task-redistribution 
include resistance from other health professionals; increasing NPHW workload due to 
additional tasks; complexity of training materials; health system-related issues such as non-
availability or non-functioning BP machines, poor drug supply, lack of physician availability 
for referral; regulatory restrictions including the inability to prescribe medications; and low 
remuneration of NPHWs.57 The key enablers included an increase in the enthusiasm and 
motivation of NPHWs to be trained and take on new roles, as well as a reduction in the 
physician workload leading to improved performance. All of these studies are currently in 
progress and will have effectiveness and cost-effectiveness results in the near future.
mHealth
mHealth is the use of mobile phones to improve and support health, and can be used for a 
variety of purposes to connect clinicians, other health workers including CHWs, and patients 
or patient caregivers (Figure 6). mHealth can be used to provide health education, promote 
behavior change, facilitate decision support in diagnosis and management of a wide variety 
of conditions, support diagnostic testing, or link medical records.58 Evidence for benefits of 
mHealth is widespread among a variety of high-income country settings, and further data are 
emerging on the use of mHealth in LMICs with respect to the impact on clinical outcomes, 
processes of care, health care costs and health related quality of life.59–61 There is great 
potential for the use of mHealth for hypertension management in LMICs as mobile phone 
ownership is high and growing rapidly, even among the poor.62 However, there still remain 
research gaps with a relatively limited number of studies in this area, particularly in 
hypertension.
Five projects within the GACD research network have a mHealth component at their core, or 
in conjunction with other innovations, in order to address barriers within health systems and 
to optimize opportunities for the detection and management of hypertension. The projects 
are taking place in communities in rural Kenya,14 rural Tanzania, both urban and rural 
Colombia and Malaysia, rural and remote Aboriginal communities in Canada, Nigeria,63 and 
rural India. All of the projects are utilizing either a smartphone- or tablet-based tool 
designed for use by community health workers (CHWs) to improve hypertension care; 
facilitate improved identification, follow-up, and tracking of patients; promote adherence to 
medications; and improve education of patients and CHWs. All of the programs have a 
component of real-time decision support. In addition, the Nigerian and Tanzanian/Canada 
program also send educational, behaviour change communication messages via text message 
directly to patients’ mobile phones, while the India project uses interactive voice response 
messaging because text messaging was not acceptable in this setting. The Kenya and India 
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projects embed educational messaging in novel audio-visual formats, so that CHWs can 
share these audio-visual materials to patients during home visits.
Some unique features among the mHealth innovations and programs should be highlighted. 
The programs in Kenya and India use an open-source platform called Open Data Kit, which 
has been utilized successfully to provide clinical decision source tools for HIV care. The 
Indian program also provides access to a mobile device that allows primary care physicians 
in government health clinics to access the health information of participants screened by 
CHWs; the device offers decision support for those participants identified at high CVD risk. 
This feature is also a component of the Tanzania-Canada program, whereby health center 
nurses and clinical officers can access all BP measurements taken for a patient by CHWs. A 
substudy of the Tanzania project is also evaluating the effectiveness of a phone-based drug 
voucher program to ensure the authenticity of drug supply and adherence factors in 
hypertension control. The Nigerian program is targeting patients who have experienced a 
stroke, who are at high risk for another stroke. Across the programs there have been 
common challenges, which include both technical and human factors. Technical factors have 
included mobile network coverage and server issues. Human factors have included 
overcoming end-user challenges with the new technology, as well as implementation delays 
due to government approval processes, equipment procurement delays, misalignment of 
incentives, competing obligations, and excessive workload for the health providers who are 
utilizing these new systems.
Polypill – Fixed-dose Combination Therapy
Most patients with hypertension generally require blood pressure (BP) lowering medication 
from multiple classes to achieve adequate control.64 The need for titration of medication and 
addition of multiple classes of drug requires multiple physician visits and this in itself can 
lead to poor adherence to prescribed medication and poor attendance at scheduled visits.65 
The requirement to take multiple medications in complex regimes also encourages poor 
adherence.66 For physicians, the need for repeated up-titrating or adding extra medications 
can lead to inertia and tacit acceptance of inadequate BP control.67, 68 Initiating anti-
hypertensive treatment with dual combination therapy not only accelerates the time taken to 
achieve control but also attains a lower final target.69, 70 For the patient, improved adherence 
has also been demonstrated without worsening the side effect profile.71 Further benefits in 
BP control can also result from simplifying up-titration regimes.70
Use of multi-modal fixed-dose combination pills (FDCs)—also known as ‘polypills’–
containing not only multiple low-dose blood pressure-lowering drugs, but also statins and 
aspirin, has the potential to reduce a person’s cardiovascular risk beyond that achieved by 
simply lowering their blood pressure, by addressing multiple risk factors concurrently in a 
single pill. Multiple large clinical trials have shown that use of ‘polypills’ in patients at high 
risk of CVD improves adherence to long-term medication with consequent improvements in 
cholesterol and blood pressure measurements, and are highly acceptable to patients and 
physicians alike (Figure 5).72, 73 The recently published HOPE-3 study utilized a polypill 
type strategy in patients at moderate CVD risk and showed a significant reduction in CV 
events in patients with hypertension.74 While reducing BP was a benefit only in those in the 
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hypertensive range, lowering cholesterol had beneficial effects in reducing fatal and non-
fatal cardiovascular events overall.75 Evidence is needed, however, on the implementation of 
such a strategy in real-life clinical contexts rather within the constraints of a highly regulated 
clinical trial.
The GACD has funded two projects looking at whether use of FDCs will improve 
management of hypertension, and also overall CVD risk, in real-life clinical contexts in 
several LMICs. The TRIple Pill vs. Usual care Management for Patients with mild-to- 
moderate Hypertension (TRIUMPH) study,76 is a prospective, open, randomized controlled 
clinical trial (n=700) of a fixed dose combination blood pressure-lowering pill (“Triple 
Pill”)-based strategy compared to usual care among individuals with persistent mild-to-
moderate hypertension on no or minimal drug therapy. The aim is to see whether early use 
of low dose FDC medications will result in faster and better control of blood pressure. The 
HOPE-4 study, being conducted in 50 urban and rural communities in Canada, Colombia, 
and Malaysia, is implementing and evaluating (compared to usual care) an evidence-based, 
contextually-appropriate program for CVD risk assessment, treatment and control involving 
simplified algorithms implemented by NPHWs, supported by e-health technologies; 
initiation of FDC of two antihypertensive drugs plus one statin; and use of treatment 
supporters to optimize long-term medication and lifestyle adherence. Both studies are 
ongoing with outcomes anticipated in the near future.
The use of a simplified strategy utilizing early introduction of inexpensive generic FDC pills 
(or ‘polypills’) is an approach with important potential to impact on what are currently 
exceedingly poor blood pressure control rates in LMICs. If found to be effective, cost-
effective, and acceptable, this approach has the potential to impact the cardiovascular health 
of significant numbers of individuals around the world.
Discussion
Elevated blood pressure is the leading global risk for mortality,1 and novel approaches for 
improving hypertension control are urgently required for LMICs. The GACD hypertension 
studies described here are beginning to disseminate outcomes, results, and lessons in relation 
to several different innovative approaches. In addition, they are well-poised to develop post-
study knowledge translation strategies. Finally, the GACD researchers have the potential to 
engage policy makers, payers, and other stakeholders, to translate the findings of individual 
research studies into sustainable and scalable interventions. Each GACD-funded project has 
designed one or more innovative approaches to enable the implementation and evaluation of 
interventions within local contexts, in order to improve care without significant disruption 
to, and increased workload of, already over-burdened health workers and health care 
systems.
All of the approaches described here have the potential to improve the cardiovascular health 
of populations in low-resource settings worldwide. Community engagement is a critical part 
of developing and introducing any new program, and increases the likelihood of successful 
uptake and implementation. Salt reduction and salt substitutes can reduce blood pressure and 
improve cardiovascular health, especially if combined with improved dietary intake of fresh 
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fruits and vegetables. Task redistribution expands the reach of delegated medical acts, 
empowers and engages community members, improves health literacy of communities, and 
improves the efficiency of the existing pool of health care providers. mHealth can 
additionally provide decision support, remote medical record access, and novel educational 
interfaces, all of which can enhance care delivery in resource-limited settings. Finally, FDC 
pills have the potential to transform the landscape of medical management of hypertension 
and CVD. The studies outlined in this report demonstrate innovative and practical methods 
of implementing all of these strategies for hypertension control in diverse environments and 
contexts worldwide.
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Key Points
• Elevated blood pressure is a major risk factor for cardiovascular 
disease, and it is the leading global risk for mortality.
• There is a need for novel approaches when addressing hypertension due 
to its growing health and economic burden on LMIC populations.
• The Global Alliance for Chronic Diseases sponsored 15 research 
projects focused on hypertension.
• These research projects have involved the development and evaluation 
of several important innovative approaches to hypertension control, 
including: community engagement, salt reduction, salt substitution, 
task redistribution, mHealth, and fixed-dose combination therapies.
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Synopsis
Elevated blood pressure, a major risk factor for ischemic heart disease, heart failure, and 
stroke, is the leading global risk for mortality. Despite global efforts to combat 
hypertension, treatment and control rates are very low in LMICs. Given the continued 
significant health and economic burden on LMIC populations, there is an urgent need to 
address the problem by way of novel approaches. The Global Alliance for Chronic 
Diseases sponsored 15 research projects focused on hypertension, which have involved 
the development and evaluation of several important innovative approaches to 
hypertension control, including: community engagement, salt reduction, salt substitution, 
task redistribution, mHealth, and fixed-dose combination therapies.
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Figure 1. 
Community engagement activities undertaken within GACD Projects. Participation activities 
denote the least level of engagement while empowerment activities denote the greatest level 
of engagement.
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Figure 2. 
Framework for salt reduction strategies, including context, activities, outputs, and 
anticipated outcomes.
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Figure 3. 
Launching a salt substitute to reduce blood pressure at the population level in Peru, divided 
into two phases.
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Figure 4. 
The process of task-redistribution for the management of hypertension adapted from the 
WHO’s recommendations on task-shifting. From World Health Organization, PEPFAR, 
UNAIDS. Task shifting: rational redistribution of tasks among health workforce teams : 
global recommendations and guidelines. http://www.who.int/healthsystems/TTR-
TaskShifting.pdf, 2016, with permission.
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Figure 5. 
Proportion of participants adherent to combination therapy at end of study in patients either 
with established CVD or at high calculated risk. Adherence is defined as taking antiplatelet, 
statin and ≥ 2 BP-lowering drugs at least 4 days of the last 7 at end of study in UMPIRE,78 
Kanyini-GAP79 and IMPACT.80 Adherence in the FOCUS73 trial was defined as pill count 
between 80 and 110% at end of study plus a score of 20/20 on the Morisky-Green 
questionnaire. Data from references 73, 78, 79, 80.
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Figure 6. 
Schematic illustrating the potential for mHealth to connect clinicians, community health 
workers (CHWs), and patients. Blue arrows indicate direct interactions among individuals. 
Red arrows indicate interactions that are facilitated by mHealth.
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ia
n 
he
al
th
 w
o
rk
er
s 
at
te
nd
 th
e 
co
m
m
un
ity
 ev
en
ts
N
PH
W
 a
tte
nd
 ev
en
ts
 
o
pp
or
tu
ni
sti
ca
lly
 w
ith
 th
e 
pe
rm
iss
io
n 
of
 ev
en
t o
rg
an
iz
er
s
Po
st
er
s e
x
pl
ai
ni
ng
 th
e 
N
PH
W
 a
tte
nd
an
ce
; c
ur
at
ed
 
co
lle
ct
io
ns
 o
f l
oc
al
 
go
v
er
n
m
en
t b
ro
ch
ur
es
 
re
ga
rd
in
g 
CV
 h
ea
lth
 a
nd
 
o
th
er
 av
ai
la
bl
e 
he
al
th
 
se
rv
ic
es
; p
er
so
na
liz
ed
 
he
al
th
y 
lif
es
ty
le
 c
ou
ns
el
lin
g 
ba
se
d 
on
 W
H
O
 
re
co
m
m
en
da
tio
ns
 
(In
ter
ve
n
tio
n-
on
ly
).
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